Complete Filing Data
FORUM MARKETS Inc reported Stockholders Equity of $11.34 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean FORUM MARKETS Inc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.2M | -$19.9M | -$38.7M | -$20.3M | -$10.9M | -$25.4M | $1.0M | $123.8K |
| Revenue * | ||||||||
| Operating Income Loss | -$6.3M | -$13.5M | -$17.9M | -$15.6M | -$5.6M | -$20.9M | -$599.1K | -$343.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$6.5M | -$22.3M | -$39.7M | -$20.3M | -$10.9M | -$25.4M | $1.5M | $319.1K |
| General And Administrative Expense | $4.4M | $10.6M | $15.5M | $11.2M | $3.2M | $5.6M | $599.1K | $343.9K |
| Income Tax Expense Benefit | -$296.0K | -$2.3M | -$942.7K | -$23.2K | -$20.4K | -$9.5K | $413.2K | $195.4K |
| Nonoperating Income Expense | -$139.5K | -$8.8M | -$21.8M | -$4.7M | -$5.3M | -$4.5M | $663.0K | |
| Operating Expenses | $6.3M | $13.5M | $17.9M | $15.6M | $5.6M | $20.9M | ||
| Comprehensive Income Net Of Tax | -$14.2M | -$20.0M | -$42.4M | -$20.1M | -$10.4M | -$25.6M | ||
| Research And Development Expense | $1.4M | $2.3M | $2.2M | $1.0M | $2.2M | $2.0M | ||
| Research And Development Related Parties | $240.7K | $2.9M | $75.6K | $54.0K | ||||
| Deferred Income Tax Liabilities Net | $304.7K | $2.6M | $3.6M | $3.7M | $3.7M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax | -$3.7M | $180.6K | $484.1K | -$160.7K | ||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$15.6K | -$15.8K | -$3.7M | |||||
| Inprocess Research And Development | $9.1M | $12.6M | $12.6M | $12.5M | ||||
| Other Comprehensive Income Loss Net Of Tax | -$3.7M | $180.6K | $484.1K | |||||
| Interest Expense | $44.8K | $28.2K | ||||||
| Other Comprehensive Income Loss Tax | -$15.8K | -$3.7M | $484.1K | -$160.7K | ||||
| General And Administrative Related Parties | $5.6K | $462.6K | $185.8K | $286.7K | ||||
| Income Loss From Continuing Operations Per Diluted Share | ||||||||
| Income Loss From Continuing Operations Per Basic Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$216.7M | -$1.7M | -$2.4M | -$836.7K | $11.8K | -$1.1M | -$10.3M | -$3.7M | -$4.8M | -$21.5M | $2.9M | $1.6M | $18.3M | -$23.5M | -$16.2M | -$829.4K | $267.4K | -$2.4M | -$21.8K | -$10.8K | $231.6K | $319.6K | $211.2K | $173.5K | $86.1K | $5.3K | -$31.3K | -$3.1K | -$683.00 |
| Revenue * | $4.1M | ||||||||||||||||||||||||||||
| Operating Income Loss | -$220.5M | -$1.7M | -$2.4M | -$596.2K | -$1.8M | -$2.1M | -$3.5M | -$3.7M | -$4.8M | -$4.1M | -$4.5M | -$3.7M | -$4.2M | -$4.0M | -$2.9M | -$731.1K | -$934.2K | -$1.6M | -$225.7K | -$296.4K | -$264.9K | -$140.3K | -$148.0K | -$137.9K | -$140.8K | -$50.4K | -$31.3K | -$3.1K | -$683.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$208.7M | -$1.7M | -$2.4M | -$532.4K | $11.8K | -$1.1M | -$12.6M | -$3.7M | -$4.8M | -$21.5M | $2.9M | $1.6M | $18.3M | -$23.5M | -$16.2M | -$834.6K | $262.4K | -$2.4M | $29.6K | $59.6K | $327.4K | $407.0K | $337.5K | $249.6K | $193.1K | $5.3K | -$31.3K | ||
| General And Administrative Expense | $224.6M | $1.4M | $2.0M | $596.2K | $1.6M | $1.6M | $2.4M | $2.8M | $4.0M | $3.4M | $4.0M | $3.0M | $3.5M | $2.7M | $2.5M | $403.4K | $388.0K | $995.3K | $225.7K | $296.4K | $264.9K | $140.3K | $148.0K | $137.9K | $140.8K | $50.4K | $31.3K | $3.1K | $683.00 |
| Income Tax Expense Benefit | -$2.3M | -$5.6K | -$5.6K | -$5.4K | -$5.1K | -$4.9K | -$5.1K | $51.3K | $70.4K | $95.8K | $87.4K | $126.3K | $76.2K | $106.9K | |||||||||||||||
| Nonoperating Income Expense | $11.8M | $3.8K | $3.7K | $63.8K | $1.9M | $1.0M | -$9.1M | $2.8K | $41.8K | -$17.4M | $7.5M | $5.2M | $22.5M | -$19.5M | -$13.3M | -$103.5K | $1.2M | $333.9K | |||||||||||
| Operating Expenses | $224.6M | $1.7M | $2.4M | $596.2K | $1.8M | $2.1M | $3.5M | $3.7M | $4.8M | $4.1M | $4.5M | $3.7M | $4.2M | $4.0M | $2.9M | $731.1K | $934.2K | $1.6M | |||||||||||
| Comprehensive Income Net Of Tax | -$216.2M | -$1.9M | -$2.4M | -$904.1K | -$9.1K | -$1.1M | -$10.2M | -$3.7M | -$4.8M | -$23.4M | $1.0M | $835.6K | $17.8M | -$23.1M | -$16.0M | -$415.1K | $1.1M | -$4.2M | |||||||||||
| Research And Development Expense | $182.4K | $240.9K | $251.6K | $118.9K | $365.2K | $972.1K | $789.4K | $216.7K | $583.2K | $446.4K | $658.9K | $316.5K | $246.6K | $99.9K | $351.0K | $472.9K | |||||||||||||
| Research And Development Related Parties | $132.9K | $131.5K | $216.7K | $53.3K | $57.3K | $47.7K | $298.9K | $747.9K | $267.1K | $112.7K | $80.1K | $30.6K | |||||||||||||||||
| Deferred Income Tax Liabilities Net | $341.7K | $300.0K | $299.4K | $278.4K | $2.7M | $2.6M | $3.5M | $3.6M | $3.6M | $3.7M | $3.7M | $3.7M | |||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax | -$15.3K | $663.00 | -$1.9M | -$1.9M | -$728.1K | -$530.8K | $406.5K | $189.3K | $414.3K | $867.2K | -$1.8M | ||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $556.6K | -$64.7K | -$67.3K | -$20.9K | $6.5K | $51.3K | -$15.3K | $663.00 | -$1.9M | $329.3K | |||||||||||||||||||
| Inprocess Research And Development | $9.1M | $9.1M | $12.3M | $12.4M | $12.5M | $12.6M | $12.6M | $12.6M | |||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$1.9M | -$1.9M | -$728.1K | -$530.8K | $406.5K | $189.3K | $414.3K | $867.2K | -$1.8M | ||||||||||||||||||||
| Interest Expense | $16.4K | $11.6K | $11.6K | $11.6K | $7.3K | $7.4K | $5.5K | $12.2K | $83.0K | $172.5K | |||||||||||||||||||
| Other Comprehensive Income Loss Tax | $51.3K | -$15.3K | $663.00 | -$1.9M | -$1.9M | -$728.1K | $189.3K | -$1.8M | |||||||||||||||||||||
| General And Administrative Related Parties | $5.3K | $340.4K | $39.1K | ||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$16.80 | -$5.43 | |||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$16.80 | -$5.43 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $11.3M | $39.3M | $30.3M | $38.6M | -$7.7M | $5.0M | $21.9K | ||
| Retained Earnings Accumulated Deficit | -$127.3M | -$107.4M | -$68.7M | -$48.4M | -$37.5M | $1.2M | $120.7K | -$3.1K | |
| Liabilities Current | $5.1M | $5.7M | $19.7M | $21.4M | $9.6M | $546.1K | $208.1K | $218.1K | |
| Liabilities And Stockholders Equity | $5.3M | $19.7M | $62.7M | $55.5M | $51.9M | $118.4M | $117.1M | $240.0K | |
| Liabilities | $5.4M | $8.3M | $23.4M | $25.2M | $13.3M | $4.6M | $4.2M | $218.1K | |
| Assets Current | $3.6M | $8.9M | $11.2M | $4.0M | $748.3K | $270.9K | $470.3K | $67.3K | |
| Assets | $5.3M | $19.7M | $62.7M | $55.5M | $51.9M | $118.4M | $117.1M | $240.0K | |
| Common Stock Value | $54.00 | $20.00 | $170.00 | $2.6K | $1.4K | $410.00 | $420.00 | $287.00 | |
| Cash And Cash Equivalents At Carrying Value | $567.2K | $428.4K | $67.3K | ||||||
| Loans Payable Current | $1.0M | $1.3M | $1.8M | $968.4K | $116.3K | ||||
| Prepaid Expense And Other Assets Current | $1.7M | $2.0M | $3.0M | $1.6M | $591.6K | ||||
| Accrued Liabilities Current | $1.9M | $2.3M | $2.0M | $4.1M | $1.7M | ||||
| Accounts Payable Current | $1.9M | $1.8M | $586.6K | $8.5M | $4.1M | ||||
| Intangible Assets Net Excluding Goodwill | $1.6M | $1.7M | $1.9M | $2.0M | $2.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $2.6M | -$5.0M | -$1.3M | $6.1M | $2.0M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.9M | $817.4K | $636.9K | $152.8K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.0M | $8.2M | |||||||
| Derivative Liabilities Current | $58.00 | $75.4K | $15.2M | $4.4M | |||||
| Cash Equivalents At Carrying Value | $7.0M | $8.2M | $2.1M | $83.4K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.1M | $83.4K | |||||||
| Cash And Cash Equivalents Period Increase Decrease | $2.0M | -$483.8K | -$157.5K | $361.1K | |||||
| Accounts Payable And Accrued Liabilities Current | $94.7K | $24.5K | $78.1K | ||||||
| Assets Held In Trust Noncurrent | $118.2M | $116.6M | |||||||
| Temporary Equity Carrying Amount Attributable To Parent | $108.9M | $107.8M | |||||||
| Repayments Of Related Party Debt | $81.3K | $431.8K | $100.0K | $200.0K | $61.6K | ||||
| Loans Payable Non Current Portion | $48.2K | $113.8K | |||||||
| Change In Value Of Common Stock Subject To Possible Redemption | -$91.3K | $1.0M | |||||||
| Deferred Underwriting Fees | $4.0M | $4.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $445.1M | $5.4M | $7.7M | $9.3M | $3.7M | -$418.0K | -$954.5K | -$127.7K | -$149.3K | $6.7M | $7.1M | $26.1M | $42.8M | $40.9M | $37.1M | $2.7M | $22.7M | $30.3M | $35.5M | $35.9M | $34.7M | $38.6M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | |||||
| Retained Earnings Accumulated Deficit | -$362.4M | -$145.6M | -$143.9M | -$141.5M | -$129.2M | -$128.4M | -$128.4M | -$126.1M | -$115.9M | -$112.2M | -$85.7M | -$64.2M | -$67.1M | -$69.7M | -$88.0M | -$64.6M | -$3.3M | -$1.5M | $852.5K | $1.4M | $1.4M | $1.4M | $824.9K | $505.3K | $315.2K | $57.0K | -$29.1K | ||||||||
| Liabilities Current | $55.8M | $5.3M | $3.9M | $3.5M | $6.4M | $4.0M | $4.1M | $4.8M | $4.3M | $5.1M | $4.7M | $7.0M | $15.1M | $24.2M | $49.8M | $33.6M | $4.0M | $3.5M | $3.2M | $2.8M | $1.4M | $1.2M | $666.5K | $719.9K | $262.7K | $239.0K | $112.8K | ||||||||
| Liabilities And Stockholders Equity | $1.01B | $10.7M | $11.7M | $12.8M | $10.5M | $3.9M | $3.4M | $5.0M | $13.7M | $14.9M | $34.3M | $53.4M | $59.7M | $65.1M | $56.3M | $60.1M | $11.0M | $12.6M | $12.4M | $51.6M | $50.2M | $66.5M | $118.2M | $118.0M | $117.3M | $117.0M | $116.8M | ||||||||
| Liabilities | $564.2M | $5.3M | $3.9M | $3.5M | $6.7M | $4.3M | $4.4M | $5.1M | $7.0M | $7.8M | $8.3M | $10.6M | $18.8M | $27.9M | $53.5M | $37.4M | $4.0M | $3.5M | $7.2M | $6.8M | $5.5M | $5.2M | $4.7M | $4.7M | $4.3M | $4.3M | $4.1M | ||||||||
| Assets Current | $561.9M | $3.1M | $4.0M | $5.1M | $1.2M | $2.3M | $1.9M | $3.4M | $2.9M | $4.2M | $6.5M | $4.6M | $9.0M | $13.6M | $4.0M | $8.3M | $721.2K | $1.2M | $387.9K | $901.0K | $208.8K | $144.7K | $543.4K | $596.8K | $390.8K | $486.0K | $607.5K | ||||||||
| Assets | $1.01B | $10.7M | $11.7M | $12.8M | $10.5M | $3.9M | $3.4M | $5.0M | $13.7M | $14.9M | $34.3M | $53.4M | $59.7M | $65.1M | $56.3M | $60.1M | $11.0M | $12.6M | $12.4M | $51.6M | $50.2M | $66.5M | $118.2M | $118.0M | $117.3M | $117.0M | $116.8M | ||||||||
| Common Stock Value | $1.7K | $604.00 | $32.00 | $103.00 | $95.00 | $86.00 | $674.00 | $532.00 | $375.00 | $3.9K | $3.4K | $3.4K | $3.4K | $3.1K | $3.1K | $528.00 | $508.00 | $448.00 | $430.00 | $426.00 | $423.00 | $413.00 | $416.00 | $418.00 | $421.00 | $422.00 | |||||||||
| Cash And Cash Equivalents At Carrying Value | $11.7M | $1.8M | $6.1M | $2.1M | $32.7K | $70.1K | $97.6K | $83.4K | $836.0K | $110.3K | $134.6K | $519.1K | $543.1K | $340.1K | $453.5K | $577.6K | $67.3K | $25.0K | |||||||||||||||||
| Loans Payable Current | $485.8K | $762.4K | $148.4K | $584.00 | $473.1K | $429.0K | $772.3K | $332.9K | $588.2K | $842.2K | $321.7K | $803.9K | $1.3M | $279.3K | $426.1K | $606.3K | |||||||||||||||||||
| Prepaid Expense And Other Assets Current | $3.0M | $873.8K | $304.2K | $477.5K | $1.0M | $1.2M | $1.2M | $708.4K | $925.8K | $1.6M | $2.9M | $3.0M | $3.3M | $1.9M | $2.2M | $1.9M | |||||||||||||||||||
| Accrued Liabilities Current | $372.9K | $623.7K | $771.1K | $4.2K | $466.3K | $559.7K | $1.4M | $2.4M | $2.5M | $2.8M | $2.1M | $1.9M | $2.6M | $2.2M | $1.9M | $2.9M | |||||||||||||||||||
| Accounts Payable Current | $1.2M | $2.2M | $2.1M | $305.6K | $2.1M | $2.6M | $1.8M | $1.7M | $837.0K | $1.2M | $1.0M | $1.6M | $1.0M | $638.6K | $2.5M | $3.9M | |||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $7.6M | $7.6M | $7.6M | $9.2M | $1.6M | $1.6M | $1.6M | $1.7M | $1.7M | $1.6M | $1.7M | $1.9M | $2.0M | $2.0M | $2.0M | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$860.6K | -$1.3M | -$4.3M | -$2.6M | $3.9M | ||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.6M | -$3.1M | -$3.0M | -$2.9M | -$3.0M | -$2.9M | -$2.8M | -$2.9M | -$2.9M | -$2.9M | -$3.7M | -$1.8M | $89.4K | $701.9K | $1.2M | $826.2K | |||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $558.9M | $2.2M | $3.7M | $4.6M | $150.1K | $1.1M | $676.0K | $1.7M | $2.7M | $2.0M | $2.6M | $3.6M | $1.6M | $5.7M | $11.7M | $1.8M | $6.1M | $2.1M | |||||||||||||||||
| Derivative Liabilities Current | $249.00 | $5.6K | $7.6K | $22.1K | $1.1M | $2.5M | $10.0M | $20.9M | $43.5M | $24.4M | |||||||||||||||||||||||||
| Cash Equivalents At Carrying Value | $676.0K | $2.0M | $2.7M | $2.0M | $2.6M | $3.6M | $1.6M | $5.7M | $11.7M | $1.8M | $6.1M | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.7M | $2.0M | $2.6M | $7.0M | $3.6M | $1.6M | $5.7M | $8.2M | |||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $3.9M | $14.2K | -$136.3K | -$88.3K | $67.3K | $25.0K | |||||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $358.3K | $339.5K | $347.2K | $268.4K | $86.4K | $59.1K | $105.8K | $64.0K | $49.3K | $56.3K | $83.1K | $105.8K | |||||||||||||||||||||||
| Assets Held In Trust Noncurrent | $10.3M | $11.3M | $12.0M | $11.9M | $50.7M | $50.0M | $66.3M | $117.7M | $117.4M | $116.9M | $116.5M | $116.2M | |||||||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $2.0M | $4.1M | $129.7K | $347.1K | $39.8M | $39.8M | $56.3M | $108.5M | $108.2M | $108.0M | $107.8M | $107.7M | |||||||||||||||||||||||
| Repayments Of Related Party Debt | $100.0K | ||||||||||||||||||||||||||||||||||
| Loans Payable Non Current Portion | $28.7K | $31.2K | $31.5K | $37.3K | $43.6K | $52.1K | $70.0K | $108.0K | |||||||||||||||||||||||||||
| Change In Value Of Common Stock Subject To Possible Redemption | -$217.4K | $231.6K | $173.5K | ||||||||||||||||||||||||||||||||
| Deferred Underwriting Fees | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.0M | $5.9M | $10.9M | $25.4M | -$8.7M | -$106.5M | $156.8K | $116.8M |
| Net Cash Provided By Used In Operating Activities | -$1.5M | -$10.9M | -$12.1M | -$19.4M | -$3.9M | -$3.3M | -$789.2K | -$497.4K |
| Increase Decrease In Accrued Liabilities | -$316.1K | -$440.6K | $319.9K | -$1.2M | $533.5K | $327.9K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.9M | -$337.3K | -$1.0M | $1.4M | $210.2K | -$427.9K | ||
| Increase Decrease In Accounts Payable | $230.4K | $1.2M | -$5.5M | $2.2M | $2.9M | |||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$197.2K | $169.8K | -$436.6K | |||||
| Stock Issued During Period Value Share Based Compensation | $2.6M | |||||||
| Net Cash Provided By Used In Investing Activities | $14.5M | -$708.1K | $474.9K | -$115.9M | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $173.7K | $70.2K | -$53.6K | |||||
| Increase Decrease In Prepaid Expense | $51.8K | -$41.9K | $41.9K | |||||
| Increase Decrease In Derivative Liabilities | -$15.1M | $4.7M | $1.8M | |||||
| Share Based Compensation | $2.2M | $2.6M | $1.1M | $340.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$3.3K | -$264.4K | -$469.8K | -$515.4K | $10.4M | $333.4K | -$52.8M | $34.0K | $67.3K | $25.0K | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$853.7K | -$1.0M | -$3.9M | -$2.1M | -$6.3M | -$409.0K | -$307.1K | -$181.1K | |||||||||||||
| Increase Decrease In Accrued Liabilities | $339.3K | -$447.9K | $526.4K | $662.9K | -$969.0K | $733.6K | |||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$480.5K | -$424.9K | $325.1K | $342.0K | -$267.7K | ||||||||||||||||
| Increase Decrease In Accounts Payable | -$621.9K | $455.0K | -$4.0M | $302.4K | |||||||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $53.7K | $36.9K | $19.3K | $28.7K | |||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $208.2M | $103.6K | $577.6K | $16.5K | $22.3K | $236.1K | $584.0K | $551.3K | $557.4K | $611.5K | $795.1K | $596.5K | |||||||||
| Net Cash Provided By Used In Investing Activities | -$66.9K | $53.0M | $58.8K | ||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $78.8K | $11.1K | -$56.6K | $31.3K | $3.1K | $683.00 | |||||||||||||||
| Increase Decrease In Prepaid Expense | $32.4K | $10.1K | $8.8K | ||||||||||||||||||
| Increase Decrease In Derivative Liabilities | -$53.3K | -$5.2M | -$22.0M | $19.2M | $13.2M | ||||||||||||||||
| Share Based Compensation | $236.1K | $557.4K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$15.49 | -$52.59 | -$387.18 | -$12.96 | -$0.66 | -$0.02 | $0.07 | $0.01 | |
| Weighted Average Number Of Shares Outstanding Basic | 915.4K | 379.1K | 100.0K | 1.6M | 4.2M | 4.2M | 3.5M | ||
| Earnings Per Share Basic | $-15.49 | $-52.59 | $-387.18 | $-12.96 | $-0.02 | $0.25 | $0.04 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 915.4K | 379.1K | 4.2M | 14.9M | 9.4M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 534.7K | 197.2K | 1.7M | 26.2M | 13.8M | 4.1M | 4.2M | 2.9M | |
| Common Stock Shares Outstanding | 534.7K | 197.2K | 1.7M | 26.2M | 13.8M | 4.1M | 4.2M | 2.9M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 35.0M | 35.0M | 35.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 1.0M | 1.0M | 1.0M | ||
| Temporary Equity Shares Outstanding | 10.8M | 10.7M | 0.00 | ||||||
| Temporary Equity Redemption Price Per Share | $0.00 | $0.00 | $10.10 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.30 | -$0.67 | -$0.85 | $0.01 | -$1.68 | -$24.53 | -$13.37 | -$24.15 | -$10.97 | $1.72 | $0.05 | $0.23 | -$0.75 | -$0.58 | -$0.05 | $0.02 | -$0.05 | -$0.01 | $0.00 | $0.02 | $0.02 | $0.01 | $0.01 | $0.01 | $0.00 | -$0.01 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 12.4M | 5.7M | 3.5M | 98.1K | 919.1K | 638.3K | 418.5K | 275.3K | 197.2K | 2.0M | 1.7M | 1.7M | 32.7M | 31.5M | 28.0M | 16.9M | 16.9M | 4.5M | 4.3M | 4.2M | 4.1M | 4.2M | 4.2M | 4.2M | 4.2M | 2.8M | 2.5M | 2.5M | 2.5M | |||
| Earnings Per Share Basic | $-0.30 | $-0.67 | $-0.85 | $0.01 | $-1.68 | $-24.53 | $-13.37 | $-24.15 | $-10.97 | $1.72 | $0.05 | $0.56 | $-0.75 | $-0.58 | $-0.05 | $0.02 | $-0.05 | $-0.01 | $0.00 | $0.06 | $0.08 | $0.05 | $0.04 | $0.02 | $0.00 | $-0.01 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 12.4M | 5.7M | 3.5M | 98.1K | 919.1K | 638.3K | 418.5K | 275.3K | 197.2K | 2.0M | 1.7M | 1.7M | 33.7M | 31.5M | 28.0M | 16.9M | 17.4M | 4.5M | 4.3M | 4.2M | 13.4M | 14.9M | 14.9M | 14.9M | 14.9M | 5.3M | 2.5M | 2.5M | 2.5M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Issued | 16.7M | 6.0M | 317.7K | 1.0M | 941.6K | 852.8K | 6.7M | 5.3M | 3.7M | 39.2M | 34.1M | 34.1M | 34.0M | 31.1M | 30.5M | 5.3M | 5.1M | 4.5M | 4.3M | 4.3M | 4.2M | 4.1M | 4.2M | 4.2M | 4.2M | 4.2M | ||||||
| Common Stock Shares Outstanding | 16.7M | 6.0M | 317.7K | 1.0M | 941.6K | 852.8K | 6.7M | 3.7M | 3.7M | 39.2M | 34.1M | 34.1M | 34.0M | 31.1M | 30.5M | 5.3M | 5.1M | 4.5M | 4.3M | 4.3M | 4.2M | 4.1M | 4.2M | 4.2M | 4.2M | 4.2M | ||||||
| Common Stock Shares Authorized | 5.00B | 100.0M | 5.00B | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | 35.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||
| Temporary Equity Shares Outstanding | 191.0K | 396.8K | 12.5K | 33.6K | 3.9M | 3.9M | 5.5M | 10.7M | 10.7M | 10.7M | 10.7M | 10.7M | ||||||||||||||||||||
| Temporary Equity Redemption Price Per Share | $10.59 | $10.41 | $10.39 | $10.33 | $0.00 | $0.00 | $0.00 | $10.10 | $10.10 | $10.10 | $10.10 | $10.10 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $130.1M | $121.6M | $107.2M | $78.0M | $75.9M | $3.8M | $4.9M | $24.7K | |
| Fair Value Adjustment Of Warrants | -$58.00 | -$75.3K | -$15.1M | $4.7M | $1.8M | ||||
| Investment Income Interest | $3.7K | $2.1M | $663.0K | ||||||
| Interest Paid Net | $12.1K | $21.7K | $15.1K | $35.4K | |||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $308.2K | $2.2M | $2.6M | $2.9M | $7.8K | ||||
| Issuance Of Stock And Warrants For Services Or Claims | $89.2K | $331.6K | $2.1M | ||||||
| Other Income | $2.8M | $21.1K | -$146.8K | $15.3K | |||||
| Total Adjustments | $26.6M | $953.2K | $7.0M | $22.1M | |||||
| Stock Redeemed Or Called During Period Value | -$108.4M | -$1.0M | -$107.8M | ||||||
| Stock Issued During Period Value Issued For Services | $60.6K | $331.6K | $2.0M | $107.7M | |||||
| Due To Related Parties Current | $369.0K | $95.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $826.2M | $155.1M | $154.6M | $153.7M | $136.0M | $130.9M | $130.4M | $128.8M | $125.5M | $122.2M | $115.4M | $108.8M | $107.9M | $106.2M | $89.5M | $86.4M | $8.3M | $6.5M | $4.1M | $3.6M | $3.6M | $3.6M | $4.2M | $4.5M | $4.7M | $4.9M | $5.0M | |
| Fair Value Adjustment Of Warrants | -$249.00 | $191.00 | -$2.0K | -$14.4K | -$53.3K | -$1.4M | -$7.5M | -$5.2M | -$22.0M | $19.2M | $13.2M | |||||||||||||||||
| Investment Income Interest | $327.2K | $266.00 | $3.0K | $35.5K | $255.3K | $356.0K | $592.3K | $547.3K | $485.4K | $387.5K | $333.9K | $55.7K | ||||||||||||||||
| Interest Paid Net | $12.1K | $7.3K | $2.9K | |||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.5K | $22.3K | $236.1K | $584.0K | $551.3K | $557.4K | $596.5K | $435.0K | $344.1K | $1.1M | ||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $572.8K | $149.7K | $925.4K | |||||||||||||||||||||||||
| Other Income | $6.5K | $6.4K | $76.6K | $1.7M | $1.0M | $12.3K | $2.6K | $12.6K | ||||||||||||||||||||
| Total Adjustments | $892.2K | -$3.6M | $9.9M | $2.0M | ||||||||||||||||||||||||
| Stock Redeemed Or Called During Period Value | $946.1K | -$4.7M | $217.4K | $21.8K | $10.8K | -$231.6K | ||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $60.6K | $60.6K | $60.6K | $149.7K | ||||||||||||||||||||||||
| Due To Related Parties Current | $795.0K | $795.0K | $795.0K | $795.0K | $696.9K | $538.8K | $491.8K | $156.2K | $49.0K | $7.0K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.